Scholars Central

Conference abstractPublished 15 Oct 2013

Design and development of unnatural nucleosides as antiviral and anti-cancer agents

Authors: Ram C. Mishra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Unnatural nucleosides are the variants (chemically modified analogs) of five natural nucleosides which constitute the structure of DNA and RNA. Since the first preparation and later, the isolation of unnatural nucleosides from plants; nucleoside chemistry has become a field of extensive medicinal importance. These nucleosides perturb the growth of cancer cells by interfering with replication process and while showing antiviral properties, act on reverse transcriptase. Since the availability of designing tools like QSAR and CADD the two main approaches in design of unnatural nucleosides are the modulation of hydrogen bondings originating from the base and change in the conformation and configuration of ribose sugar counterpart. Currently approved anticancer drugs like gemcitabine and clofarabine (working on polymerase and ribonucleotide reductase) are the fluorinated analogs of the adenosine and cytidine respectively. Similarly, zidovudine (AZT) and zalcitabine (ddC) are the examples of first line of unnatural antiviral drugs acting on reverse transcriptases. Unnatural nucleosides can be categorized into four broad categories namely, base modifiled, sugar modified, C-Nucleosides and carbocylclics. Design of antiviral drugs, apart from molecular modeling and computer aides also takes its clues from some unnatural nucleosides isolated from natural sources like neplanocins and aristeromycin. This special class of unnatural nucleosides is known as carbocyclic nucleosides, and is currently major source of antiviral drugs for HBV and HCV therapy. The salient feature of carbanucleosides lies in the fact that they don?t really have a furanose sugar ring, instead a puckered cyclopentane ring. This gives them two major advantages, making them resistant to enzymatic lyses and at the same time being recognized by receptors of natural nucleosides.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ram C. Mishra”